ARCHIVES

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

This article is from The Cancer Letter archive.

Vol. 10 No. 33 | August 31, 1984

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Vogel To Succeed Yates As VP for Research At American Cancer Society.

October 17, 2008

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

November 29, 2002

Executive Summary of Centers, SPOREs Report

February 28, 2003

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999